What is the ticker symbol for Akari Therapeutics?

Akari Therapeutics trades under the ticker AKTX on NASDAQ.

What sector does Akari Therapeutics operate in?

Akari Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AKTX in a portfolio?

PortView shows AKTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Akari Therapeutics (AKTX) Stock Analysis

NASDAQHealthcareBiotechnology

$9.91-4.44%

1-year price historyRange $3.06 – $44.80

52-week range$9.91

$3.02$49.60

What Akari Therapeutics does

Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company’s lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bladder, head and neck, gastric, pancreatic, colon, prostate, and others. Its payloads include PH1 is a novel payload that is a spliceosome modulator designed to disrupt RNA splicing within cancer cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Tampa, Florida.

Key metrics

Market cap

$11.34M

P/E (TTM)

-2.21

EPS (TTM)

$-4.48

Beta

1.39

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$9.60

200-day avg

$10.05

52-week high

$49.60

52-week low

$3.02

CEO

Abizer Gaslightwala

ETFs linked to AKTX

Broad-market and Healthcare sector ETFs an investor holding Akari Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AKTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AKTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Akari Therapeutics?: Akari Therapeutics trades under the ticker AKTX on NASDAQ.
Which exchange is AKTX listed on?: AKTX is listed on NASDAQ.
What sector does Akari Therapeutics operate in?: Akari Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AKTX in a portfolio?: PortView shows AKTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.